- Filed
- Oct 23, 2026
- Last modified
- Oct 23, 2026
- Petitioner
- Medtronic, Inc
- Inventor
- Ahmnon D. Moskowitz et al
Invalidity dossier
US 12491088
Added 10/24/2026, 12:00:16 AM
Active provider: DeepSeek · deepseek-flash
Patent summary
Title, assignee, inventors, filing/issue dates, abstract, and a plain-language overview of the claims.
Patent overview — US 12491088 B2
Title: Expandable spinal spacer device
Patent number: US 12491088 B2 (application US 18/663,585; pre-grant publication US 20240366399 A1)
Assignee: Moskowitz Family LLC (listed as current and original assignee).
Inventors: Ahmnon D. Moskowitz; Mosheh T. Moskowitz; Pablo A. Valdivia y Alvarado; Eric Sugalski; Nathan C. Moskowitz; David Schoon.
Dates: Priority date 2012‑10‑25 (externally claimed from US 14/063,197, published as US 9848993 B2); priority filing event 2013‑10‑25; application filed 2024‑05‑14; publication of the pre-grant application 2024‑11‑07; patent granted 2025‑12‑09. Listed legal status: active, with an adjusted expiration of 2033‑11‑22. The source notes that the legal status, priority date, and assignee entries are assumptions and not legal conclusions.
Purpose and plain-language scope: Judging from the title, the listed prior-art keywords ("spacer device," "tool," "wedge," "bone," "expandable spinal"), and the classifications, the patent concerns an intervertebral (spinal) spacer that can be expanded in place—a fusion cage-type implant placed between spinal bodies, together with associated tools and techniques such as wedges and insertion/instrumentation aids. The classifications also cover bone drills and guides, bone staples/fasteners, spinal stabilizers acting on vertebral facets, joint distractors for the spine, and implant insertion/extraction tools, suggesting the described system may extend beyond the implant to surgical instrumentation and related fixation.
What the excerpt does not establish: The supplied text is only the bibliographic/classification front page of the Google Patents record. It does not include the abstract, claims, written description, or drawings. Therefore it is not possible to state, from this source, the specific claimed structure, the exact mechanism of expansion, the number or scope of claims, the specific embodiments, or the precise clinical method. No verification of enablement, validity, claim breadth, or freedom to operate is possible from this excerpt, and no such conclusions should be drawn. Litigation, ownership transfers, and prior-art analysis were outside the requested scope and were not researched; the record does note family litigation and a Minnesota District Court case (0:25‑cv‑00769), but details are not established here.
Generated 10/24/2026, 12:00:49 AM
Cases on file (0)
Specific litigation cases in our database that name US patent 12491088. The free-form analysis below may also discuss cases beyond this list.
No cases on file mention this patent. Upload a CSV or add a case manually in Admin → Manage litigation cases.
Litigation summary
Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.
Proceedings on file (1)
All PTAB activity →AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Assignment history
Inventors, original assignee, and the chain of ownership recorded with the USPTO — including the correspondent attorney who recorded each assignment, since shell-LLC chains often share one repeat-player attorney even when the entity names look unrelated. Surfaces NPE / patent-troll patterns: shell-entity transfers, known asserters in the chain, repeat correspondent fingerprints, pre-litigation assignments, and bankruptcy fire-sales.
Prior art
Earlier patents, publications, and products that may anticipate or render the claims unpatentable.
Obviousness
Combinations of prior art that suggest the claimed invention would have been obvious under 35 U.S.C. § 103.
Extensions
Patent term adjustments, term extensions, continuations, divisionals, family members, and expiration dates.
Derivative works
Defensive disclosure: derivative variations of each claim designed to render future incremental improvements obvious or non-novel.